Ambarani, Anesan .

HRN: 26-30-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFUROXIME 750MG (VIAL)
08/06/2025
08/13/2025
IV
200mg
Q8hours
PCAP-B
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines